Ob/Gyn Articles

Ob/Gyn

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Wiedemann C et al. – The authors data suggest that progesterone and CMA can inhibit proliferation of human melanocytes, which counteracts the stimulatory effects of estrogen. This may be of relevance for the choice of progestogen in oral contraceptives to prevent the development of melasma.

Related Articles

Cross-Talk between Estrogen Receptor and Epidermal Growth Factor Receptor in Head and Neck Squamous Cell Carcinoma
Clinical Cancer Research, 10/19/09    Relevance Score: 67%

Fertility Preservation for Breast Cancer Patients
Seminars in Reproductive Medicine, 10/08/09    Relevance Score: 66%

Endometrial Cancer
American Family Physician, 11/12/09    Relevance Score: 65%

Immune changes in post-menopausal osteoporosis: The Immunos study
Osteoporosis International, 11/03/09    Relevance Score: 65%

Estrogen and selective estrogen receptor modulators regulate vascular endothelial growth factor and soluble vascular endothelial growth factor receptor 1 in human endometrial stromal cells
Fertility and Sterility, 10/14/09    Relevance Score: 65%

Today in Preventive Medicine...keeping you current

Autoimmune Thyroid Disease in Pregnancy: A Review
Journal of Women's Health, 12/11/09

A Pilot Safety and Tolerability Study of a Nonhormonal Vaginal Contraceptive Ring
The Journal of Reproductive Medicine, 12/11/09

Mifepristone: ten years later
Contraception, 12/11/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address